GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$520M
AUM Growth
+$63.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$33.5M
2
+$17M
3
+$15M
4
PCRX icon
Pacira BioSciences
PCRX
+$13.9M
5
RNAC icon
Cartesian Therapeutics
RNAC
+$13.8M

Top Sells

1
+$24.9M
2
+$15.2M
3
+$10.7M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$10.4M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$7.34M

Sector Composition

1 Healthcare 84.97%
2 Technology 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$41.2M 7.92%
+2,439,930
2
$38.8M 7.46%
2,216,351
-385,000
3
$36.4M 7%
2,232,238
4
$35.4M 6.81%
2,440,959
5
$34.8M 6.7%
1,900,000
+431,479
6
$32.1M 6.18%
7,223,509
7
$27.9M 5.37%
2,000,000
-200,000
8
$27.6M 5.31%
600,000
+40,000
9
$24.9M 4.78%
910,569
10
$22.2M 4.27%
4,781,708
+1,100,000
11
$22.1M 4.25%
276,800
+265,283
12
$19.4M 3.73%
243,800
-58,009
13
$18.6M 3.58%
+31,250
14
$18.1M 3.48%
1,749,323
-1,321,977
15
$17.9M 3.43%
50,000
+1,408
16
$15M 2.88%
493,500
+193,500
17
$14.3M 2.75%
+300,000
18
$9.3M 1.79%
311,000
-3,724
19
$9.24M 1.78%
+538,473
20
$8.95M 1.72%
435,402
+312,947
21
$8.03M 1.54%
+121,428
22
$7.22M 1.39%
2,924,015
-130,985
23
$7.13M 1.37%
+88,500
24
$6.99M 1.34%
255,400
-44,600
25
$4.2M 0.81%
+435,500
1
2